中国地方病学杂志
中國地方病學雜誌
중국지방병학잡지
CHINESE JOURNAL OF ENDEMIOLOGY
2011年
6期
646-648
,共3页
戴瑞霞%祁芝珍%任玲玲%张青雯%李存香%魏荣杰%吴海莲%王效义%王祖郧
戴瑞霞%祁芝珍%任玲玲%張青雯%李存香%魏榮傑%吳海蓮%王效義%王祖鄖
대서하%기지진%임령령%장청문%리존향%위영걸%오해련%왕효의%왕조운
耶尔森菌,鼠疫%抗原%抗体%免疫
耶爾森菌,鼠疫%抗原%抗體%免疫
야이삼균,서역%항원%항체%면역
Yersinia pestis%Antigens%Antibodies%Immunity
目的 对小鼠血清抗体滴度检测和对小鼠的保护力观察,评价鼠疫菌荚膜抗原(F1抗原)和重组rV270抗原对鼠疫的免疫保护效果.方法 40只6~8周雌性Balb/c小鼠,按体质量随机分成4个实验组(F1-10 μg+铝佐剂、F1-20μg+铝佐剂、rV-10 μg+铝佐剂、rV-20 μg+铝佐剂)和1个对照组,每组8只.将天然F1抗原和重组rV270抗原分别吸附到25%铝佐剂中免疫实验组小鼠,对照组小鼠以免疫等量的铝佐剂.每只动物每次后腿肌肉免疫100 μ1,初次免疫后,第21天加强免疫1次.所有动物分别于第1次免疫后第8周采血,酶联免疫吸附试验(ELISA)测定抗体滴度.同时用2000倍半数致死量(LD50)的鼠疫菌141强毒株皮下攻毒,观察14d,以观察免疫后保护效果.结果 对照组未产生抗体,F1-10 μg+铝佐剂组、F1-20 μg+铝佐剂组的抗体几何平均滴度(GMT)分别为1∶30443.9、1∶21527.8,组间比较差异无统计学意义(t=1.1282,P>0.05);rV-10 μg+铝佐剂组和rV-20μg+铝佐剂组的GMT分别为1∶13957.3、1∶18100.9,组间比较差异无统计学意义(t=0.9408,P>0.05).用141强毒株皮下攻毒后,实验组小鼠全部存活,对照组8只小鼠全部死亡.结论 实验用天然F1抗原及重组rV270抗原具有较高的免疫活性,可作为鼠疫亚单位疫苗的主要组分用于鼠疫亚单位疫苗的研究.
目的 對小鼠血清抗體滴度檢測和對小鼠的保護力觀察,評價鼠疫菌莢膜抗原(F1抗原)和重組rV270抗原對鼠疫的免疫保護效果.方法 40隻6~8週雌性Balb/c小鼠,按體質量隨機分成4箇實驗組(F1-10 μg+鋁佐劑、F1-20μg+鋁佐劑、rV-10 μg+鋁佐劑、rV-20 μg+鋁佐劑)和1箇對照組,每組8隻.將天然F1抗原和重組rV270抗原分彆吸附到25%鋁佐劑中免疫實驗組小鼠,對照組小鼠以免疫等量的鋁佐劑.每隻動物每次後腿肌肉免疫100 μ1,初次免疫後,第21天加彊免疫1次.所有動物分彆于第1次免疫後第8週採血,酶聯免疫吸附試驗(ELISA)測定抗體滴度.同時用2000倍半數緻死量(LD50)的鼠疫菌141彊毒株皮下攻毒,觀察14d,以觀察免疫後保護效果.結果 對照組未產生抗體,F1-10 μg+鋁佐劑組、F1-20 μg+鋁佐劑組的抗體幾何平均滴度(GMT)分彆為1∶30443.9、1∶21527.8,組間比較差異無統計學意義(t=1.1282,P>0.05);rV-10 μg+鋁佐劑組和rV-20μg+鋁佐劑組的GMT分彆為1∶13957.3、1∶18100.9,組間比較差異無統計學意義(t=0.9408,P>0.05).用141彊毒株皮下攻毒後,實驗組小鼠全部存活,對照組8隻小鼠全部死亡.結論 實驗用天然F1抗原及重組rV270抗原具有較高的免疫活性,可作為鼠疫亞單位疫苗的主要組分用于鼠疫亞單位疫苗的研究.
목적 대소서혈청항체적도검측화대소서적보호력관찰,평개서역균협막항원(F1항원)화중조rV270항원대서역적면역보호효과.방법 40지6~8주자성Balb/c소서,안체질량수궤분성4개실험조(F1-10 μg+려좌제、F1-20μg+려좌제、rV-10 μg+려좌제、rV-20 μg+려좌제)화1개대조조,매조8지.장천연F1항원화중조rV270항원분별흡부도25%려좌제중면역실험조소서,대조조소서이면역등량적려좌제.매지동물매차후퇴기육면역100 μ1,초차면역후,제21천가강면역1차.소유동물분별우제1차면역후제8주채혈,매련면역흡부시험(ELISA)측정항체적도.동시용2000배반수치사량(LD50)적서역균141강독주피하공독,관찰14d,이관찰면역후보호효과.결과 대조조미산생항체,F1-10 μg+려좌제조、F1-20 μg+려좌제조적항체궤하평균적도(GMT)분별위1∶30443.9、1∶21527.8,조간비교차이무통계학의의(t=1.1282,P>0.05);rV-10 μg+려좌제조화rV-20μg+려좌제조적GMT분별위1∶13957.3、1∶18100.9,조간비교차이무통계학의의(t=0.9408,P>0.05).용141강독주피하공독후,실험조소서전부존활,대조조8지소서전부사망.결론 실험용천연F1항원급중조rV270항원구유교고적면역활성,가작위서역아단위역묘적주요조분용우서역아단위역묘적연구.
Objective To evaluate the protective effect of Yersinia pestis capsular antigen F1 and recombinant rV270 on mice after immunization with them.Methods According to body weight,40 female Balb/c mice aged 6 to 8 weeks were randomly divided into four experimental groups(Fl-10 μg + aluminum adjuvant,F1-20 μg + aluminum adjuvant,rV-10 μg + aluminum adjuvant,and rV-20 μg + aluminum adjuvant) and a control group,8 in each group.Mice in experimental groups were immunized with the natural antigen F1 and recombinant antigen rV270 adsorbed to 25% aluminum adjuvant and the control group was immunized with the same amount of aluminum adjuvant.Each mouse was immunized at the hind leg muscle with 100 ml immunizing agent,then a booster immunization was done once on the 21st day after the first immunization.The blood of all mice was collected on the 8th week after the first immunization,serum antibody titers were detected by ELISA and the data of antibody titers were analyzed by t test for comparison between groups.At the same time the mice were injected subcutaneously with 2000-fold LD50 of Yersinia pestis virulent strain 141,after 14 days,the protective effect of immunization was analyzed.Results The control group did not produce antibody.Antibody geometric mean titers (GMT) of the F1-10 mg + aluminum adjuvant and F1-20 mg + aluminum adjuvant groups were 1 ∶ 30443.9,and 1 ∶21527.8,respectively,and compared between the two groups,the difference was not statistically significant (t =1.1282,P > 0.05).The GMTs of the rV-10 μg + aluminum adjuvant and rV-20 μg + aluminum adjuvant groups were 1 ∶ 13957.3 and 1 ∶18100.9,respectively,and compared between the two groups,the difference was not statistically significant(t =0.9408,P > 0.05 ).After subcutaneous injection with Yersinia pestis virulent strain 141,all mice died in the control group but all survived in the experimental group.Conclusion The immune activity of natural antigen F1 and recombinant rV270 is high,which can be used as the main component of subunit vaccine in the plague subunit vaccine study.